Does age play a factor in parenteral nutrition induced liver disease and/or cholestasis even among reducing lipid emulsions?

Written By Emma Alvarez-Roth

It’s said that cholestasis resulting in parenteral nutrition associated liver disease (PNALD) is found among babies and young children (1).

- How does this affect those of other ages and/or those with growth delays?

- How does age impact the risk of liver disease alongside long term PN use?

Source:

  1. Jolin-Dahel, K., Ferretti, E., Montiveros, C., Grenon, R., Barrowman, N., & Jimenez-Rivera, C. (2013). Parenteral nutrition-induced cholestasis in neonates: where does the problem lie?. Gastroenterology research and practice, 2013, 163632. https://doi.org/10.1155/2013/163632.

Emma Alvarez-Roth
Previous

How does hunger work with those who’s nutritional needs are met but can’t eat orally?
Next

What quality of life research is available for those on long term TPN?